# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016990
Filing Date
2023-05-15
Accepted
2023-05-15 09:25:54
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1066392
2 |  | ex10-2.htm | EX-10.2 | 25105
3 |  | ex31-1.htm | EX-31.1 | 18135
4 |  | ex31-2.htm | EX-31.2 | 18122
5 |  | ex32.htm | EX-32 | 10090
6 |  | ex99-1.htm | EX-99.1 | 33922
7 |  | ex99-1_001.jpg | GRAPHIC | 5427
| Complete submission text file | 0001493152-23-016990.txt |  | 5810091

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | envb-20230331.xsd | EX-101.SCH | 42260
9 | XBRL CALCULATION FILE | envb-20230331_cal.xml | EX-101.CAL | 46707
10 | XBRL DEFINITION FILE | envb-20230331_def.xml | EX-101.DEF | 186722
11 | XBRL LABEL FILE | envb-20230331_lab.xml | EX-101.LAB | 359523
12 | XBRL PRESENTATION FILE | envb-20230331_pre.xml | EX-101.PRE | 279587
56 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1043785

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 23919006
SIC: 2834 Pharmaceutical Preparations